When you include the American Institute for Cancer Research in your estate plans, you make a major difference in the fight against cancer.

Corporate Champions who partner with the American Institute for Cancer Research stand at the forefront of the fight against cancer

40 Years of Progress: Transforming Cancer. Saving Lives.

The AICR Lifestyle & Cancer Symposium addresses the most current and consequential issues regarding diet, obesity, physical activity and cancer.

The Annual AICR Research Conference is the most authoritative source for information on diet, obesity, physical activity and cancer.

Cancer Update Program – unifying research on nutrition, physical activity and cancer.

ResourcesNav New164

Whether you are a healthcare provider, a researcher, or just someone who wants to learn more about cancer prevention, we’re here to help.

Read real-life accounts of how AICR is changing lives through cancer prevention and survivorship.

We bring a detailed policy framework to our advocacy efforts, and provide lawmakers with the scientific evidence they need to achieve our objectives.

AICR champions research that increases understanding of the relationship between nutrition, lifestyle, and cancer.

Are you ready to make a difference? Join our team and help us advance research, improve cancer education and provide lifesaving resources.

AICR’s resources can help you navigate questions about nutrition and lifestyle, and empower you to advocate for your health.

Research Projects > 2010 Grantees

Obesity-induced IGF-1 Coordinately Upregulates COX-2 and Downregulates Tumor Suppressive PGDH Resulting in Enhanced Pancreatic Cancer Growth

Project Description

This study is examining the hypothesis that the increased levels of insulin-like growth factor (IGF-1) caused by obesity alter the levels of several hormones and growth factors. The substances then lead to chronic inflammation, which may contribute to pancreatic cancer development. The study will treat specialized pancreatic cancer cells with IGF-1 and examine the levels of several substances in the pancreas of lean, overweight and obese mice and in mice that lack circulating IGF-1.

Leave a Reply

Your email address will not be published. Required fields are marked *

More News & Updates